Skip to content

31% of African TB now due to HIV epidemic

HIV-positive gay men not a risk group for HCV coinfection in US urban cohort

Atazanavir in treatment-experienced people: boosted looks better

Atazanavir approval recommended in US

Recent HSV infection substantially increases chances of HIV infection

Expert panel maps global 'HIV prevention gap': $6 billion needed by 2007

SA government gets chance to rethink AIDS treatment policy

T-cell activation means lower CD4 gains in HAART treated HIV patients

Switch from d4T to abacavir gives `modest` fat gains